The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Isn’t he still in PL75’s basement?!
Thanks Titania, I’m also curious about the impact of the Japanese goblin!
Totally agree, I’ve not sold any yet, the potential is getting clearer and larger.
Congratulations Ghia!
It would be appreciated if you would, I would certainly like to read it please.
BBC news just now:
“ The BBC has been told a cabinet decision on whether to introduce airport testing has been repeatedly postponed and now may never happen.”
For info only, I am well aware our market is so much bigger than this!
Also said “in under 90 mins”, not 10 mins.
Twitter commentary suggesting Novacyt (not saying that’s right!, just an observation).
Yes, Money Section, James Comey wrote headed ‘If Only’.
“Things I wish I’d invested in at the start of the year: Perspex screen manufacturers, face mask makers Netflix, Synairgen, Zoom” other obvious things included in the list, but no other companies except those three.
The point of the short article was that people should be diversified.
Courtesy of Canute40 on the AVCT board just now:
According to Scott Gottieib in the video link below, it will be about rolling out Plasma treatment with EUA clearance
https://twitter.com/FaceTheNation/status/1297557532806918145
Yes I am, use Spreadex, pretty good, but sometimes they lock the market for a while.
I also use IG, which is almost always available, but deposit requirements are slightly higher with IG.
It also suggests that if it is going to be sold for about £5, then talk of £3 profit per test for Avacta may be too high and expectations need to be managed down a bit.
As we all know, if we made profit of just 50p - £1 per test that’s still a whole lot of profit.
Same for me (SNG average 50p), they’re both looking great!
Love that, I thought it was only me who liked the ‘2:30’ joke.
£3bn is huge money, but if things work out as they could to, £3bn would be a fraction of what it is worth.
Clearly that would take time to see in the SP and there’s many hurdles to cross, but most definitely a potential outcome.
Totally agree RScorpio.
You’re definitely not mad.
Oops yes!
£10bn plus I meant.
I agree, with a broker forecast order book of £1-2bn before end of 2020, any buyout needs to be 8 figures before I’d vote for it.
Buying prior to drinking is also a wise move however!
IMV £3bn isn’t enough to buy us out, given the broker forecasts that we could have an order book of £1-2bn before end of this year.
Clearly there are still some risks and hurdles to cross, but when you look at the potential and current market cap - £10bn isn’t completely ridiculous as an outcome (albeit not going to happen in August or September).
That’s almost £70 per share - that’s when it sounds ridiculous - I’m still holding all of mine. GLA